Association of Major Adverse Cardiovascular Events in Patients With Stroke and Cardiac Wall Motion Abnormalities
| Autor: | Saadat, Kamran, Naveed, Akhtar, Rajvir, Singh, Yahya, Imam, Khawaja H, Haroon, Noman, Amir, Suhail, Hussain, Salman, Al Jerdi, Laxmi, Ojha, Ahmed, Own, Ahmad, Muhammad, Jonathan D, Perkins |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Heart Ventricles Incidence Middle Aged Myocardial Contraction Risk Assessment major adverse cardiovascular events cardiac wall motion abnormalities Stroke Risk Factors embolic stroke Clinical Studies Ventricular Dysfunction Humans Cerebrovascular Disease/Stroke Female cardiovascular diseases embolic stroke of undetermined source Tomography X-Ray Computed Qatar Follow-Up Studies Retrospective Studies Original Research |
| Zdroj: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| ISSN: | 2047-9980 |
| Popis: | Background The association of cardiac wall motion abnormalities (CWMAs) in patients with stroke who have major adverse cardiovascular events (MACE) remains unclear. The purpose of this study was to estimate the 50‐month risk of MACE, including stroke recurrence, acute coronary events, and vascular death in patients with stroke who have CWMAs. Methods and Results We performed a retrospective analysis of prospectively collected acute stroke data (acute stroke and transient ischemic attack) over 50 months by electronic medical records. Data included demographic and clinical information, vascular imaging, and echocardiography data including CWMAs and MACE. Of a total of 2653 patients with acute stroke/transient ischemic attack, CWMA was observed in 355 (13.4%). In patients with CWMAs, the embolic stroke of undetermined source (50.7%) was the most frequent index stroke subtype and stroke recurrences (P=0.001). In multivariate Cox regression after adjustment for demographics, traditional risk, and confounding factors, CWMA was independently associated with a higher risk of MACE (adjusted hazard ratio [HR], 1.74; 95% CI, 1.37–2.21 [P=0.001]). Similarly, CWMA independently conferred an increased risk for ischemic stroke recurrence (adjusted HR, 1.50; 95% CI, 1.01–2.17 [P=0.04]), risk of acute coronary events (aHR, 2.50; 95% CI, 1.83–3.40 [P=0.001]) and vascular death (adjusted HR, 1.57; 95% CI, 1.04–2.40 [P=0.03]), in comparison to the patients with stroke without CWMA. Conclusions In a multiethnic cohort of ischemic stroke with CWMA, CWMA was associated with 1.7‐fold higher risks of MACE independent of established risk factors. Embolic stroke of undetermined source was the most common stroke association with CWMA. Patients with stroke should be screened for CWMA to identify those at higher risk of MACE. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text